Cargando…

Is cancer a prognostic factor for severe COVID-19, especially for breast cancer patients?

The coronavirus disease 2019 (COVID-19) pandemic has caused a global upheaval in our health care system. Our hospital facilities have been subjected to a major influx of patients and the prevention of cross-contamination has been a key issue in the spread of the virus. New recommendations for good h...

Descripción completa

Detalles Bibliográficos
Autores principales: Allali, S., Beddok, A., Kirova, Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Société française de radiothérapie oncologique (SFRO). Published by Elsevier Masson SAS. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8245377/
https://www.ncbi.nlm.nih.gov/pubmed/34274225
http://dx.doi.org/10.1016/j.canrad.2021.06.015
_version_ 1783716102954549248
author Allali, S.
Beddok, A.
Kirova, Y.
author_facet Allali, S.
Beddok, A.
Kirova, Y.
author_sort Allali, S.
collection PubMed
description The coronavirus disease 2019 (COVID-19) pandemic has caused a global upheaval in our health care system. Our hospital facilities have been subjected to a major influx of patients and the prevention of cross-contamination has been a key issue in the spread of the virus. New recommendations for good hygiene practice and new recommendations for disease management have emerged to limit the spread of the virus and reorganize the provision of care in key services. Many studies have attempted to identify factors that contribute to poor prognosis for COVID-19 infection. Among them, cancer patients, were considered more at risk of developing severe forms of COVID-19. In this article, we provide an overview of the current state of the pandemic as well as new recommendations for disease management that have emerged in oncology and radiation therapy in particular. In this article, we will try to provide some answers through a review of the literature to the question: is cancer a prognostic factor for severe COVID-19?
format Online
Article
Text
id pubmed-8245377
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Société française de radiothérapie oncologique (SFRO). Published by Elsevier Masson SAS.
record_format MEDLINE/PubMed
spelling pubmed-82453772021-07-01 Is cancer a prognostic factor for severe COVID-19, especially for breast cancer patients? Allali, S. Beddok, A. Kirova, Y. Cancer Radiother Review Article The coronavirus disease 2019 (COVID-19) pandemic has caused a global upheaval in our health care system. Our hospital facilities have been subjected to a major influx of patients and the prevention of cross-contamination has been a key issue in the spread of the virus. New recommendations for good hygiene practice and new recommendations for disease management have emerged to limit the spread of the virus and reorganize the provision of care in key services. Many studies have attempted to identify factors that contribute to poor prognosis for COVID-19 infection. Among them, cancer patients, were considered more at risk of developing severe forms of COVID-19. In this article, we provide an overview of the current state of the pandemic as well as new recommendations for disease management that have emerged in oncology and radiation therapy in particular. In this article, we will try to provide some answers through a review of the literature to the question: is cancer a prognostic factor for severe COVID-19? Société française de radiothérapie oncologique (SFRO). Published by Elsevier Masson SAS. 2022-05 2021-07-01 /pmc/articles/PMC8245377/ /pubmed/34274225 http://dx.doi.org/10.1016/j.canrad.2021.06.015 Text en © 2021 Société française de radiothérapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Review Article
Allali, S.
Beddok, A.
Kirova, Y.
Is cancer a prognostic factor for severe COVID-19, especially for breast cancer patients?
title Is cancer a prognostic factor for severe COVID-19, especially for breast cancer patients?
title_full Is cancer a prognostic factor for severe COVID-19, especially for breast cancer patients?
title_fullStr Is cancer a prognostic factor for severe COVID-19, especially for breast cancer patients?
title_full_unstemmed Is cancer a prognostic factor for severe COVID-19, especially for breast cancer patients?
title_short Is cancer a prognostic factor for severe COVID-19, especially for breast cancer patients?
title_sort is cancer a prognostic factor for severe covid-19, especially for breast cancer patients?
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8245377/
https://www.ncbi.nlm.nih.gov/pubmed/34274225
http://dx.doi.org/10.1016/j.canrad.2021.06.015
work_keys_str_mv AT allalis iscanceraprognosticfactorforseverecovid19especiallyforbreastcancerpatients
AT beddoka iscanceraprognosticfactorforseverecovid19especiallyforbreastcancerpatients
AT kirovay iscanceraprognosticfactorforseverecovid19especiallyforbreastcancerpatients